Pyxis Oncology, Inc. (PYXS)
USD 1.52
(-6.75%)
USD 1.52
(-6.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 2 Million | 1.83 Million | 1.25 Million | 444 Thousand | - |
| Gross Profit | -2 Million | -1.83 Million | -1.25 Million | -444 Thousand | - |
| Operating Expenses | 82.19 Million | 123.48 Million | 69.71 Million | 12.89 Million | 2.87 Million |
| Selling, General and Administrative Expenses | 30.83 Million | 37.35 Million | 18.66 Million | 3.84 Million | 1.65 Million |
| Research and Development Expenses | 49.58 Million | 86.12 Million | 51.05 Million | 9.04 Million | 1.22 Million |
| Other Expenses | - | - | 181 Thousand | - | - |
| Cost and Expenses | 82.19 Million | 123.48 Million | 69.71 Million | 12.89 Million | 2.87 Million |
| Operating Income | -82.19 Million | -123.48 Million | -69.71 Million | -12.89 Million | -2.87 Million |
| Interest Expense | - | - | - | - | - |
| Income Tax Expense | - | -2.76 Million | 5.56 Million | -66 Thousand | -107 Thousand |
| Earnings before Tax | -73.79 Million | -120.71 Million | -75.97 Million | -12.82 Million | -2.77 Million |
| Net Income | -73.79 Million | -117.95 Million | -81.53 Million | -12.76 Million | -2.66 Million |
| Earnings Per Share Basic | -1.85 | -3.57 | -2.53 | -0.37 | -0.08 |
| Earnings Per Share Diluted | -1.85 | -3.57 | -2.53 | -0.37 | -0.08 |
| Weighted Average Shares Outstanding | 39.9 Million | 33.03 Million | 32.22 Million | 34.3 Million | 34.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.9 Million | 33.03 Million | 32.22 Million | 34.3 Million | 34.3 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -78.49 Million | -122.77 Million | -69.07 Million | -12.42 Million | - |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 16.14 Million | 3.42 Million | - | - | - |
| Cost of Revenue | 585 Thousand | 1.59 Million | 763 Thousand | 2 Million | 677 Thousand | 699 Thousand |
| Gross Profit | -585 Thousand | 14.55 Million | 2.65 Million | -2 Million | -677 Thousand | -699 Thousand |
| Operating Expenses | 19.44 Million | 20.16 Million | 17 Million | 80.19 Million | 25.35 Million | 18.12 Million |
| Selling, General and Administrative Expenses | 6.07 Million | 8.24 Million | 6.16 Million | - | 10.66 Million | 6.73 Million |
| Research and Development Expenses | 13.36 Million | 11.91 Million | 10.84 Million | - | 14.68 Million | 11.39 Million |
| Other Expenses | 708 Thousand | 799 Thousand | 576 Thousand | - | 598 Thousand | 564 Thousand |
| Cost and Expenses | 20.03 Million | 21.75 Million | 17.76 Million | 82.19 Million | 25.35 Million | 18.12 Million |
| Operating Income | -20.03 Million | -5.6 Million | -17.76 Million | -82.19 Million | -25.35 Million | -18.12 Million |
| Interest Expense | - | - | 1.71 Million | - | - | - |
| Income Tax Expense | - | 1.07 Million | 3.89 Million | - | -523 Thousand | -1.65 Million |
| Earnings before Tax | -17.3 Million | -3.25 Million | -15.59 Million | -73.79 Million | -23.04 Million | -15.9 Million |
| Net Income | -17.3 Million | -3.25 Million | -15.59 Million | -73.79 Million | -23.04 Million | -15.9 Million |
| Earnings Per Share Basic | -0.29 | -0.06 | -0.35 | - | -0.56 | -0.41 |
| Earnings Per Share Diluted | -0.29 | -0.06 | -0.35 | - | -0.56 | -0.41 |
| Weighted Average Shares Outstanding | 60.49 Million | 51.28 Million | 44.75 Million | 39.9 Million | 41.33 Million | 38.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.49 Million | 51.28 Million | 44.75 Million | 39.9 Million | 41.33 Million | 38.38 Million |
| Gross Margin | - | 0.90 | 0.78 | - | - | - |
| EBIT Margin | - | -0.28 | -4.97 | - | - | - |
| Profit Margin | - | -0.20 | -4.56 | - | - | - |
| EBITDA | -19.44 Million | -4.48 Million | -17 Million | - | -25.35 Million | -17.59 Million |
| Earnings Before Tax Margin | - | -0.35 | -5.20 | - | - | - |
I3E
JETR
RBW
TECK-B
DRTSW
MMMW